These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 18923838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.
    Balletshofer BM, Stock J, Rittig K, Lehn-Stefan A, Braun N, Burkart F, Plontke S, Klingel R, Häring HU.
    Ther Apher Dial; 2005 Oct; 9(5):385-90. PubMed ID: 16202012
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss.
    Kostal M, Drsata J, Bláha M, Lánská M, Chrobok V.
    J Otolaryngol Head Neck Surg; 2017 Jun 29; 46(1):50. PubMed ID: 28662721
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.
    Egli Gallo D, Khojasteh E, Gloor M, Hegemann SC.
    Audiol Neurootol; 2013 Jun 29; 18(3):161-70. PubMed ID: 23446332
    [Abstract] [Full Text] [Related]

  • 9. Apheresis for idiopathic sudden hearing loss: reviewing the evidence.
    Finger RP, Gostian AO.
    J Clin Apher; 2006 Dec 29; 21(4):241-5. PubMed ID: 16532475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, Goebel JA, Hammerschlag PE, Harris JP, Isaacson B, Lee D, Linstrom CJ, Parnes LS, Shi H, Slattery WH, Telian SA, Vrabec JT, Reda DJ.
    JAMA; 2011 May 25; 305(20):2071-9. PubMed ID: 21610239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E.
    Otol Neurotol; 2011 Apr 25; 32(3):393-7. PubMed ID: 21221047
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.
    Laryngoscope; 2007 Jan 25; 117(1):3-15. PubMed ID: 17202923
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.